Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (5): 496-502    DOI: 10.19485/j.cnki.issn2096-5087.2022.05.015
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
浙江省居民麻疹抗体水平调查
严睿, 周洋, 邓璇, 唐学雯, 朱瑶, 何寒青
浙江省疾病预防控制中心免疫规划所,浙江 杭州 310051
Serum anti-measles antibody levels among residents in Zhejiang Province
YAN Rui, ZHOU Yang, DENG Xuan, TANG Xuewen, ZHU Yao, HE Hanqing
Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou,Zhejiang 310051, China
全文: PDF(877 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2018年浙江省居民麻疹抗体水平,为麻疹防控提供依据。方法 于2018年采用多阶段整群随机抽样方法,抽取浙江省0~59岁常住居民为调查对象,通过问卷调查收集人口学信息、麻疹病史和含麻疹成分疫苗(MCV)免疫史等资料;检测麻疹病毒IgG抗体水平,计算抗体几何平均浓度(GMC)。分析不同年龄、地区居民麻疹抗体阳性率、保护率和GMC差异。结果 调查4 189人,其中男性1 939人,女性2 250人,男女性别比为1∶1.16。麻疹抗体阳性3 858人,阳性率为92.10%;达到抗体保护性水平2 072人,抗体保护率为49.46%;抗体GMC MQR)为798.33(1 024.06)mIU/mL。麻疹抗体保护率随年龄增长呈下降趋势(χ2趋势=18.067,P<0.001)。不同地区居民麻疹抗体阳性率(χ2=45.090,P<0.001)、保护率(χ2=57.432,P<0.001)和GMC(χ2=88.624,P<0.001)比较,差异均有统计学意义。其中宁波市抗体阳性率较低(85.19%),舟山市抗体保护率(38.98%)和GMC[632.89(909.04)mIU/mL]较低;湖州市抗体阳性率(95.16%)、保护率(58.48%)和GMC[1 035.84(1 301.77)mIU/mL]均较高。结论 2018年浙江省居民麻疹抗体保护率偏低,且随年龄增长呈下降趋势;麻疹抗体水平存在地区差异。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
严睿
周洋
邓璇
唐学雯
朱瑶
何寒青
关键词 麻疹抗体保护率几何平均浓度含麻疹成分疫苗    
AbstractObjective To investigate the serum levels of anti-measles antibody among residents in Zhejiang Province in 2018, so as to provide insights into measles control. Methods Permanent residents aged 0 to 59 years were recruited using the stratified multistage random sampling method in Zhejiang Province in 2018, and subjects' demographic features, medical history of measles and history of immunization with measles-containing vaccine (MCV) were collected using a questionnaire survey. The serum level of anti-measles IgG antibody was detected, and the geometric mean concentration (GMC) of anti-measles IgG antibody was estimated. The seroprevalence, protective rate and GMC of anti-measles IgG antibody were compared among residents at different age groups and regions. Results A total of 4 189 residents were enrolled, including 1 939 males and 2 250 females, with a male to female ratio of 1∶1.16. There were 3 858 residents positive for anti-measles IgG antibody, with seroprevalence of 92.10%, and there were 2 072 residents with protective antibodies against measles, with a protective rate of 49.46%. The median GMC of anti-measles IgG antibody was 798.33 (interquartile range, 1 024.06) mIU/mL, and the protective rate of anti-measles IgG antibody appeared a tendency towards a decline with age ( χ2trend=18.067, P<0.001 ). There were significant differences in the seroprevalence ( χ2=45.090, P<0.001 ), protective rate ( χ2=57.432, P<0.001 ) and GMC of anti-measles IgG antibody (χ2=88.624, P<0.001 ) among residents at different regions, with the lowest seroprevalence of anti-measles IgG antibody in Ningbo City ( 85.19% ), the lowest antibody-protective rate (38.98%) and the lowest GMC [632.89 ( 909.04 ) mIU/mL] in Zhoushan City, the highest seroprevalence ( 95.16% ), antibody-protective rate (58.48%) and GMC [1 035.84 ( 1 301.77 ) mIU/mL] in Huzhou City. Conclusions The protective rate of anti-measles antibody was low and appeared a tendency towards a decline among residents in Zhejiang Province in 2018. There was a region-specific serum level of anti-measles antibody in Zhejiang Province in 2018.
Key wordsmeasles    antibody-protective rate    geometric mean concentration    measles-containing vaccine
收稿日期: 2021-12-29      修回日期: 2022-03-03     
中图分类号:  R272.22  
基金资助:2022 年浙江省卫生健康科技计划项目(2022KY721)
通信作者: 何寒青,E-mail:hanqinghe@cdc.zj.cn   
作者简介: 严睿,硕士,副主任医师,主要从事免疫规划工作
引用本文:   
严睿, 周洋, 邓璇, 唐学雯, 朱瑶, 何寒青. 浙江省居民麻疹抗体水平调查[J]. 预防医学, 2022, 34(5): 496-502.
YAN Rui, ZHOU Yang, DENG Xuan, TANG Xuewen, ZHU Yao, HE Hanqing. Serum anti-measles antibody levels among residents in Zhejiang Province. Preventive Medicine, 2022, 34(5): 496-502.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.05.015      或      http://www.zjyfyxzz.com/CN/Y2022/V34/I5/496
[1] PATEL M K,GOODSON J L,ALEXANDER J P,et al.Progress toward regional measles elimination-worldwide,2000-2019[J].MMWR,2020,69(45):1700-1705.
[2] 马超,郝利新,温宁,等.中国2019年麻疹流行病学特征[J].中国疫苗和免疫,2020,26(5):493-497.MA C,HAO L X,WEN N,et al.Epidemiology of measles in China,2019[J].Chin J Vaccines Immunization,2020,26(5):493-497.
[3] 张兵,严睿,何寒青,等.浙江省2013年麻疹疫情时空分布特征[J].中华流行病学杂志,2016,37(4):548-552.ZHANG B,YAN R,HE H Q,et al.Spatial-temporal distribution feature of measles in Zhejiang province,2013[J].Chin J Epidemiol,2016,37(4):548-552.
[4] 何寒青,潘金仁,严睿,等.浙江省消除麻疹策略10项措施实施情况及效果评价[J].中国疫苗和免疫,2015,21(1):46-50,95.HE H Q,PAN J R,YAN R,et al.Evaluation of implementation of ten measurements for measles elimination in Zhejiang Province[J].Chin J Vaccines Immunization,2015,21(1):46-50,95.
[5] WANG Z F,YAN R,HE H Q,et al.Difficulties in eliminating measles and controlling rubella and mumps:a cross-sectional study of a first measles and rubella vaccination and a second measles,mumps,and rubella vaccination[J/OL].PLoS One,2014,9(2)(2014-02-20)[2022-03-03].https://doi.org/10.1371/journal.pone.0089361.
[6] YAN R,HE H Q,ZHOU Y,et al.Study on factors associated with seroprotection after measles vaccination in children of 6-14 years in Eastern China[J].Vaccine,2019,37(36):5185-5190.
[7] 姚红岑,赵家俊,任佳,等.上海市金山区健康人群麻疹抗体水平检测分析[J].中华微生物学和免疫学杂志,2017,37(12):910-914.YAO H C,ZHAO J J,REN J,et al.Anti-measles antibody levels in health people in Jinshan District of Shanghai[J].Chin J Microbiol Immunol,2017,37(12):910-914.
[8] HU Y,LU P S,DENG X Y,et al.The declining antibody level of measles virus in China population,2009-2015[J/OL].BMC Public Health,2018,18(1)(2018-07-24)[2022-03-03].https://doi.org/10.1186/s12889-018-5759-0.
[9] CHEN L H,XIAO Y Y,YANG Y H,et al.A cross-sectional study on serum measles antibody levels of a healthy population in southwest China[J/OL].Medicine,2019,98(43)(2019-10-25)[2022-03-03].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824821.DOI:10.1097/MD.0000000000017507.
[10] QIN S R,DING Y,YAN R,et al.Measles in Zhejiang,China,2004-2017:population density and proportion of floating populations effects on measles epidemic[J].Health Secur,2019,17(3):193-199.
[11] SCHENK J,ABRAMS S,THEETEN H,et al.Immunogenicity and persistence of trivalent measles,mumps,and rubella vaccines:a systematic review and meta-analysis[J].Lancet Infect Dis,2021,21(2):286-295.
[12] 卢亦愚,董红军.麻疹[M].北京:人民卫生出版社,2016:189-190.LU Y Y,DONG H J.Measles[M].Beijing:People's Medical Publishing House,2016:189-190.
[13] 严睿,何寒青,周洋,等.浙江省6~15岁儿童高浓度抗麻疹病毒抗体影响因素分析[J].浙江大学学报(医学版),2018,47(2):169-173.
YAN R,HE H Q,ZHOU Y,et al.Influencing factors for high level measles antibodies among 6-15 year-old children in Zhejiang province[J].J Zhejiang Univ(Med Sci),2018,47(2):169-173.
[1] 张超, 沈建勇, 罗小福, 徐秦儿, 韩利萍. 2015—2021年湖州市MMR疫苗疑似预防接种异常反应监测结果[J]. 预防医学, 2023, 35(1): 74-77.
[2] 严睿, 林乃珩, 李智, 孙翔, 王斌冰, 朱瑶, 何寒青, 吕华坤. 医务人员含麻疹成分疫苗接种意愿调查[J]. 预防医学, 2022, 34(9): 876-880.
[3] 方泉均, 尹志英, 郑灿杰, 龚晓英, 李俊姬. 衢州市居民麻疹血清流行病学调查[J]. 预防医学, 2022, 34(4): 408-412.
[4] 彭枭然, 王凤双, 肖雷, 黄蓉. 顺义区外来务工人员麻疹疫苗接种的影响因素分析[J]. 预防医学, 2021, 33(3): 286-288,291.
[5] 蒋雪峰, 陆晓娟, 郭林杰, 朱音, 陆叶. 浙江省首起D8基因型麻疹暴发调查[J]. 预防医学, 2018, 30(8): 819-821,824.
[6] 林茜,周令,王旭阳. 大连市8月龄~2岁儿童麻疹发病特征及影响因素分析[J]. 预防医学, 2018, 30(6): 636-638.
[7] 姜锡能, 王辉, 何丽波, 杜煜文. 兰溪市健康人群麻疹抗体水平分析[J]. 预防医学, 2018, 30(5): 508-509,512.
[8] 刘艳, 许二萍, 张小平, 张学潮, 王骏, 许玉洋, 车鑫仁, 杜渐, 顾雯雯. 杭州市医护人员接种麻疹疫苗的影响因素分析[J]. 预防医学, 2018, 30(1): 50-54.
[9] 李双飞, 马佳, 冯梅, 陈惠婵. 儿童含麻疹成分疫苗接种综合干预效果评价[J]. 预防医学, 2017, 29(8): 823-824,827.
[10] 李万仓, 魏晶娇, 王志刚, 郑晓春, 陈玲萍, 孙肖瑜. 温州市7岁以下儿童麻疹发病及影响因素研究[J]. 预防医学, 2017, 29(5): 464-467.
[11] 陈茂芳, 吴爱兰, 陈爽, 张静. 东阳市麻疹流行特征与免疫策略分析[J]. 预防医学, 2017, 29(5): 498-500.
[12] 何奔,向泽林,沈国初,杜哲群,朱红良. 嘉兴市麻疹流行特征分析及监测评价[J]. 预防医学, 2017, 29(4): 372-375.
[13] 李滨, 丁善飞. 采用非整秩次秩和比法综合评价麻疹监测系统质量[J]. 预防医学, 2017, 29(11): 1133-1135,1138.
[14] 马旭, 罗央努, 陈子涵. 慈溪市麻疹流行病学分析[J]. 预防医学, 2016, 28(9): 916-918.
[15] 吴永, 闫克栋, 陆静珠, 洪潞. 2例全程免疫麻疹类疫苗的恶性肿瘤患者感染麻疹病毒报告[J]. 预防医学, 2016, 28(9): 927-929.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed